Targeting mitochondrial dysfunction in neurodegenerative disease: Part II.

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Neurodegenerative Diseases

Background:

• Increasing life expectancy has led to a rise in neurodegenerative diseases.
• Mitochondrial dysfunction is a significant factor in neurodegeneration pathogenesis.
• Targeting mitochondria presents a potential therapeutic strategy.

Purpose of the Study:

• To review the role of mitochondrial dysfunction in neurodegeneration.
• To examine defects including oxidative stress, bioenergetic dysfunction, and calcium mishandling.
• To explore newer implicated defects such as fusion/fission, protein import, and signaling pathways.

Main Methods:

• Comprehensive literature review of mitochondrial defects in neurodegeneration.
• Analysis of common (e.g., Alzheimer's disease) and rare (e.g., Charcot-Marie-Tooth) disorders.
• Focus on both extensively researched and recently implicated mitochondrial defects.

Main Results:

• Mitochondrial defects are evident across various neurodegenerative conditions.
• Existing therapies targeting mitochondria have yielded mixed clinical trial results.
• Preclinical research is exploring novel therapeutic avenues based on enhanced understanding.

Conclusions:

• Mitochondrial dysfunction is a critical hallmark of neurodegenerative diseases.
• Current mitochondrially-targeted therapies show potential but require further validation.
• Emerging research into novel mitochondrial targets offers hope for future treatments.